Changes to both schedules include new and updated recommendations for COVID-19 vaccine, change to trivalent influenza vaccines
THURSDAY, Jan. 16, 2025 (HealthDay News) — The Advisory Committee on Immunization Practices (ACIP)-approved immunization schedules for children and adolescents and for adults for 2025 have been published in the Jan. 16 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Anindita N. Issa, M.D., from the CDC in Atlanta, and colleagues issued the ACIP-approved “Recommended Immunization Schedule for Children and Adolescents Ages 18 Years or Younger, United States, 2025,” which provides a summary of current recommendations for vaccinating children and adolescents. The authors note that changes in the 2025 immunization schedule compared with the 2024 schedule include new and updated recommendations for the COVID-19 vaccine, Haemophilus influenzae type b vaccines, influenza vaccines, and meningococcal serogroup B vaccines. Recommended influenza vaccines have been changed from the quadrivalent to the trivalent formulation.
A. Patricia Wodi, M.D., also from the CDC, and colleagues issued the ACIP-approved “Recommended Immunization Schedule for Adults Ages 19 Years or Older, United States, 2025,” which provides a summary of current recommendations for adult vaccinations. The authors note that vaccine-specific changes to the 2025 schedule compared with the 2024 schedule include new and updated recommendations for the COVID-19 vaccine, influenza vaccines, meningococcal serogroup B vaccines, pneumococcal conjugate vaccines, and respiratory syncytial virus vaccines. Recommended influenza vaccines have been changed from the quadrivalent to the trivalent formulation.
“For vaccines that appear in both the adult immunization schedule and the child and adolescent immunization schedule, the language in both schedules has been harmonized to the greatest extent possible,” Wodi and colleagues write.
One author from both studies disclosed ties to the publishing industry.
Maternal Flu, Tdap Shots May Lower Rates of Infant Hospitalization, ED Visits 
Missing First MMR Shot Most Significant Predictor of Nonvaccination by Age 2 Years 
One Dose of HPV Vaccine Noninferior to Two Doses 
Trends Reported in Vaccination Coverage for Adolescents for 2025 
Composite Dietary Antioxidant Index Inversely Linked to Cervical Cancer Prevalence 
Odds of HPV-Related Cancers Up for People With HIV, Solid Organ Transplant Recipients 
Thyroid Eye Disease Tied to Higher Prevalence of Human Papillomavirus 
.jpeg)
